• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form EFFECT filed by AIxCrypto Holdings Inc.

    12/12/25 12:15:14 AM ET
    $AIXC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AIXC alert in real time by email
    Notice of Effectiveness
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    Notice of Effectiveness
    Effectiveness Date: December 11, 2025 4:30 P.M.
    Form: S-1
    CIK: 0001460702
    Company Name: AIxCrypto Holdings, Inc.
    File Number: 333-291926
    Get the next $AIXC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIXC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AIXC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Wang Jiawei claimed ownership of 1,658 shares (SEC Form 3)

    3 - AIxCrypto Holdings, Inc. (0001460702) (Issuer)

    12/5/25 7:46:10 PM ET
    $AIXC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIXC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AIxCrypto Co-CEO Jerry Wang Shares Weekly Investor Update: $10 million FFAI Strategic Investment, 1M+ Wallets, and Sei Collaboration

    LOS ANGELES, Feb. 2, 2026 /PRNewswire/ -- AIxCrypto Inc. (NASDAQ: AIXC, "AIxC" or the "Company"), an advanced interactive platform bridging Web2 to Web3 with Embodied AI (EAI) and Real World Asset (RWA), today shared a weekly business update from Jerry Wang, Co-CEO of AIxC. "FF has signed a stock purchase agreement with a designated third party identified by AIxC." AIXC will fund FF $10 million, before offering expenses, and FF will issue the third party with $10 million in FF Class A common stock based on the most recent closing price prior to the closing date. Closing is expected to occur on or shortly after February 13, 2026, subject to customary closing conditions and stockholder approv

    2/2/26 11:21:00 AM ET
    $AIXC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AIxC and Sei Development Foundation Announce Strategic Collaboration

    LOS ANGELES, Feb. 2, 2026 /PRNewswire/ -- AIxCrypto Inc. (NASDAQ:AIXC, ", AIxC", or the ", Company", )), a U.S.-Nasdaq listed company dedicated to building a world-leading ecosystem that integrates AI and blockchain while bridging Web2 and Web3, and the Sei Development Foundation today announced a strategic technology collaboration to explore opportunities in high-performance blockchain infrastructure. Sei Development Foundation is an independent US non-profit dedicated to the advancement and adoption of open source, permissionless protocols like Sei Network – the fastest EVM Layer-1 blockchain built to support world-scale decentralized applications.

    2/2/26 11:21:00 AM ET
    $AIXC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AIxCrypto Inc. Surpasses 1.1 Million Registered Wallets as AIxC Hub Launches "Tenki" Interactive Game

    LOS ANGELES, Jan. 28, 2026 /PRNewswire/ -- AIxCrypto Inc. (NASDAQ:AIXC, ", AIxC", or the ", Company", )), an advanced interactive platform bridging Web2 to Web3 with Embodied AI (EAI) and Real World Asset (RWA), today announced that total registered wallets on AIxC Hub have exceeded 1.1 million, coinciding with the launch of Tenki, a new AI-powered interactive game now available within the platform's Playground section. Tenki: AI Agent–Driven Interactive Entertainment Tenki is an AI agent–driven interactive game designed for entertainment, inspired by culturally rooted metaphy

    1/28/26 3:01:00 PM ET
    $AIXC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIXC
    SEC Filings

    View All

    AIxCrypto Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - AIxCrypto Holdings, Inc. (0001460702) (Filer)

    2/2/26 5:03:24 PM ET
    $AIXC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by AIxCrypto Holdings Inc.

    SCHEDULE 13G/A - AIxCrypto Holdings, Inc. (0001460702) (Subject)

    1/29/26 4:05:27 PM ET
    $AIXC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AIxCrypto Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - AIxCrypto Holdings, Inc. (0001460702) (Filer)

    1/6/26 1:32:44 PM ET
    $AIXC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIXC
    Leadership Updates

    Live Leadership Updates

    View All

    AIxC Appoints Andrew Grossman As Head of Legal Where He Will Direct the Company's Legal, Compliance, and Governance Strategy

    LOS ANGELES, Dec. 17, 2025 /PRNewswire/ -- AIxCrypto Inc. (NASDAQ:AIXC, ", AIxC", or ", the Company", )) today announced the appointment of Andrew Grossman as Head of Legal. In this role, Andrew will direct the Company's legal, compliance, and governance functions, managing key areas including SEC disclosures, fund and investment compliance, digital asset and Web3 protocol architecture, and major strategic and commercial agreements. Andrew brings extensive experience in securities regulation, digital asset ecosystem architecture, strategic corporate structuring, IP strategy, a

    12/17/25 1:01:00 AM ET
    $AIXC
    $FFAI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Auto Manufacturing
    Industrials